Results 231 to 240 of about 185,125 (388)

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

open access: yesArthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors [PDF]

open access: bronze, 2001
S. Xue   +4 more
openalex   +1 more source

Development of a consolidated bioprocess for the production of citric acid using Aspergillus niger as biocatalyst

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract The industrial production of citric acid, an ingredient in beverages, pharmaceuticals, and cosmetics, is based on microbial fermentation of glucose or sucrose. Given the elevated cost of these sugars, lignocellulosic biomass is emerging as a cost‐effective and environmentally friendly feedstock for sustainable bioprocesses.
Ludovica Varriale   +4 more
wiley   +1 more source

A modified 14C-urea breath test eliminates false negative results in patients taking a proton pump inhibitor (PPI).

open access: bronze, 2000
Krishna Chathadi   +4 more
openalex   +1 more source

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging. [PDF]

open access: yesDEN Open
Uchida R   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy